🔎 Trials Near Me

Utama › Kanser Kolorektal › Wisconsin › Milwaukee

Kajian klinikal Kanser Kolorektal di Milwaukee, WI

11 kajian untuk Kanser Kolorektal sedang mencari peserta di lokasi dalam dan sekitar Milwaukee (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The Vanguard Study: Testing a New Way to Screen for Cancer

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Zablocki Veterans Administration Medical Center, Milwaukee
Umur 45 hingga 75 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06995898

Family Communications After Genetic Testing

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • dan 5 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07143487

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Mengambil pesertaFasa 2
  • Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
  • Ascension Saint Francis Hospital-Milwaukee, Milwaukee
  • dan 6 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • dan 9 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Mengambil pesertaFasa 1
  • Exelixis Clinical Site #33, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Mengambil pesertaFasa 1
  • Research Site, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05877599

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Mengambil pesertaFasa 3
  • Medical College Of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06750094

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Research Site, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06218914

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Mengambil peserta
  • Froedtert Hospital, Milwaukee
Umur 65 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07227077

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • dan 10 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Mengambil pesertaKajian pemerhatian
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • dan 11 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jan 2026 · NCT06073431

Kajian Kanser Kolorektal di bandar lain

Kajian lain di Milwaukee

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.